Gains:
- Ability to use artificial intelligence in recognizing adverse drug reactions (side effects), causality assessment and preparing TÜFAM notification draft
- Ability to complete the notification text safely by verifying it in terms of completeness, confidentiality and official format
- Ability to understand that causality judgment in pharmacovigilance reporting requires expert evaluation and that artificial intelligence only produces a draft
Once a drug hits the market, its story doesn't end; The real safety information accumulates once real patients start using the drug. Pharmacovigilance (drug safety monitoring) is the science of collecting, evaluating and preventing adverse drug reactions (unwanted, harmful drug effects). The pharmacist is one of the front-line eyes of this system: he is the one who turns the patient's phrase "I had a rash after this medication" into a health signal. In this process, AI saves time in documenting, drafting, and producing checklists. But the judgment of causality (whether the effect is truly due to the drug) is a clinical assessment and cannot be delegated to AI. In this unit, you will learn how to safely conduct adverse effect monitoring and reporting with artificial intelligence support.
Adverse effects and importance of reporting
Adverse drug reaction (ADR) is a harmful and undesirable effect caused by a drug used in normal doses. These can be mild (rash, nausea) or severe (hospitalization, permanent damage, death). In Türkiye, these notifications are made to TÜFAM (Turkish Pharmacovigilance Center). Notifications:
- It monitors the safety profile of drugs on the market in the real world.
- It reveals rare side effects (those not detected in clinical studies).
- When necessary, it forms the basis for warning, restriction or withdrawal decisions.
For a pharmacist, reporting is not only a legal duty but a direct contribution to patient safety. But to be effective, notification must be complete, accurate and confidential; This is where artificial intelligence helps.
A basic principle about which situations should be reported is this: when in doubt, report. Any reaction, especially with serious (hospitalization, permanent damage, life-threatening), unexpected (not included in the SmPC) and newly launched drugs, is a valuable signal. A single statement alone does not constitute evidence; But when the reports of thousands of pharmacists and physicians come together, a “signal” (a statistical sign of a possible safety problem) emerges. AI can help you quickly assess whether an incident meets reporting criteria; But leaving it to AI to decide “this isn't worth reporting” could lead to an important signal being lost.
Tip: A good adverse reaction report includes four basic elements: an identifiable patient (such as age/gender, not identity), the suspected drug(s), a description of the reaction, and the reporter. AI is a good reminder to check the completeness of these four elements.
Causation: Where artificial intelligence will stop
Assessment of causality is “is this effect really due to this drug?” It is the answer to the question and weighs the following: temporal relationship (time harmony between the drug and its effect), alternative causes (another drug, disease), dechallenge when the drug is stopped, recovery when given again (rechallenge) and information in the literature. This is a clinical judgment; Artificial intelligence can list these elements in a framework, but the exact causality decision is made by the expert. AI saying "it's definitely drug related" is not evidence.
three mini cases
Case 1 — Skin rash. A 45-year-old patient reported widespread rash 3 days after just starting an antibiotic. The pharmacist asked the AI for a notification draft and missing-information checklist. The artificial intelligence asked about areas such as the patient's age, the date of medication start, and the onset of the rash. The pharmacist completed the information, self-assessed causality (strong temporal concordance, no other new drugs) and sent the notification in TÜFAM format. Artificial intelligence ensured that no field was left empty.
Case 2 — Two questionable drugs. One patient experienced increased liver values after starting two new medications. The artificial intelligence noted, "Both drugs are suspicious, it should be distinguished which is responsible." The pharmacist reported both as suspect drugs and left the determination of causality to the clinical evaluation of the physician. The AI didn't hastily blame a single drug; It accurately reflected the uncertainty.
Case 3 — Preventing confidentiality failure. A pharmacist accidentally wrote the patient's name into the text while drafting the notification. The anonymization prompt flagged the remaining identifying information in the draft and warned "age/gender sufficient, name not required." The pharmacist pulled out his identification information. Artificial intelligence prevented a privacy breach.
Step-by-step adverse effect reporting (artificial intelligence supported)
- Catch the event. Obtain reaction and timing from patient/recording.
- Set up anonymous context. Age, gender, relevant clinical information instead of identity.
- Request an outline and checklist. Get notification draft and missing-field list from AI.
- Evaluate the causality yourself. Temporal relationship, alternatives, dechallenge; with a doctor if necessary.
- Verify completeness and confidentiality. Are the required fields filled, is the ID clear?
- Send in official format. Forward and save to TÜFAM/relevant system.
Weak prompt / Strong prompt
Weak: "Report this side effect."
Strong: "Prepare a notification draft and mandatory-field checklist for the following adverse reaction. Patient (anonymous): 45 years old, female. Suspect drug: [name], onset [date]. Reaction: [description], onset [date]. Other drugs: [...]. Present the draft in ORDER of the elements to be evaluated for causality (temporal relationship, alternative cause, dechallenge), but do not judge causality; leave this to the expert. Do not request identification."
In the strong prompt, anonymous context, required fields, and causality boundary are clear.
Four copyable templates
Task: Adverse effect reporting outline (making a JUDGMENT of causality).Patient (anonymous): age [...], gender [...].Suspect drug(s): [name, dose, start date].Reaction: [description, onset, course, severity].Other drugs/conditions: [...].Output: structured outline + warning of missing/empty space.
Task: Produce causality EVALUATION FRAMEWORK (not a decision). Sort: 1) Temporal relationship 2) Alternative causes 3) Course after stopping the drug (dechallenge)4) Status of re-administration 5) Recognition in the literature. Write each item as a question; The expert will fill in the result.
Task: Report completeness checklist. Check for: identifiable patient (not ID), suspected drug, reaction description, reporter information, dates, severity, outcome. List missing fields.
Task: Scan notification text for privacy.Text: [...]. If there is identification information (name, ID, address, phone), mark it and suggest "replace with anonymous equivalent". Maintain clinical significance.
Reaction severity and priority table
seriousness
example
Notification priority
The role of artificial intelligence
lightweight
Temporary nausea, mild rash
Standard
Outline + checklist
medium
Loss of work force, requiring dose change
priority
Draft + completeness
serious
Hospitalization, permanent damage
urgent
Quick draft; causality to the expert
unexpected/new
Reaction not in the SmPC
high
Literature pre-screening + confirmation
Common mistakes
- Letting artificial intelligence decide causality. Causation is clinical judgment; AI only provides the framework.
- Leaving identification information. No name/TC is required in the notification; The anonymous equivalent is sufficient.
- Send with missing field. If required fields are not complete, the notification loses its value.
- Not reporting it as mild. Unexpected reactions, although slight, carry signal value.
- Reducing multiple suspected drugs to one. If unclear, all suspects are reported.
In summary
Pharmacovigilance is an invisible but vital layer of patient safety, and the pharmacist is the front-line eye of this system. Artificial intelligence notification drafting speeds up this task and reduces the margin of error with completeness checking and privacy scanning. However, causality assessment is a clinical judgment and belongs to the expert; AI only provides an evaluation framework. It is the pharmacist's responsibility to complete the notification completely, anonymously and in accordance with the official format.
Application task
Set up an anonymised adverse effect scenario from your actual practice (age, gender, suspected drug, reaction, dates). Ask the AI for a notification outline, a causality assessment framework, and a completeness checklist. Evaluate the causality yourself (with a physician if necessary) and record it in the draft. Finally, run the privacy scan prompt and verify that there is no identifying information left in the draft.
checklist
- [ ] I got the reaction and timing right.
- [ ] I anonymized the context (no ID, only age/gender).
- [ ] I produced the draft and the missing-field list.
- [ ] I evaluated the causality myself/with an expert, I did not leave it to artificial intelligence.
- [ ] I checked the completeness of the required fields.
- [ ] I cleared the credentials with the privacy scan.
- [ ] I sent it in official format and saved it.